z-logo
Premium
Hematopoietic and nonhematopoietic cells promote Type I interferon‐ and TLR7‐dependent monocytosis during low‐dose LCMV infection
Author(s) -
Buechler Matthew B.,
Gessay Griffin M.,
Srivastava Shivani,
Campbell Daniel J.,
Hamerman Jessica A.
Publication year - 2015
Publication title -
european journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.272
H-Index - 201
eISSN - 1521-4141
pISSN - 0014-2980
DOI - 10.1002/eji.201445331
Subject(s) - lymphocytic choriomeningitis , monocytosis , tlr7 , biology , haematopoiesis , immunology , interferon , bone marrow , interferon type i , virology , microbiology and biotechnology , toll like receptor , innate immune system , antigen , immune system , stem cell , cd8
Release of inflammatory monocytes from the bone marrow (BM) into the blood is an important physiological response to infection, but the mechanisms regulating this phenomenon during viral infection are not completely defined. Here, we show that low‐dose infection with lymphocytic choriomeningitis virus (LCMV) caused rapid, transient inflammatory monocytosis that required type I interferon (IFN) and Toll‐like receptor (TLR) 7 signaling. Type I IFN and TLR7 signals were critical for induction of IFN‐stimulated gene expression and CCR2 ligand upregulation in the BM microenvironment in response to LCMV infection. Experiments utilizing BM chimeric mice demonstrated that type I IFN and TLR7 signaling on either hematopoietic or nonhematopoietic cells was sufficient to initiate monocytosis in response to LCMV infection. BM plasmacytoid dendritic cells (pDCs) generated type I IFN directly ex vivo, suggesting that pDCs are a hematopoietic contributor of type I IFN in the BM early during LCMV infection. Overall, we describe novel roles for type I IFN and TLR7 signaling in nonhematopoietic cells and BM pDCs in directing IFN‐stimulated gene and CCR2 ligand expression in the BM to initiate an increase in blood inflammatory monocytes during viral infection.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here